Pluristem Therapeutics Inc (PSTI)

[EichKing]

May I offer:

First there is no share value to crush. Management has done a fine job of that for the last 13 years. The reason this stock wallows and degrades is simple.....they don't generate any cash....and you need cash to run a business. Continual dilution, including 2 RS is a huge concern, and this is their method of running PSTI....guess what fellas...the gravy train is over.....deliver a commercial product.

Secondly, they have no proven products and few human subjects that have been through clinicals that PROVE efficacy. IC endpoint of walking distance and a few hip surgery patients is not very compelling. Lack of products means no method of generating cash.....see above.

Lastly, competitors are scary, yes. However, your comment just proves lack of effective leadership. UTHR ditched them and are moving forward in the exact indication they were partnered with PSTI on. China ditched them and others are partnering with Chinese companies. Tons of cell manufacturers out there now....and PSTI boasts 3-D manufacturing, but we have to buy toll processing and distribution from TFS....Scott did a nice job of exposing this shortfall. Now ARS, where we are supposedly light years ahead....your point is valid about competition here, but make no mistake....cash and lack of effective leadership are the main problems with PSTI.